Cataract surgery is the most common surgical intervention worldwide.

Post-surgery management of patients is key to preventing infection and treating inflammation. An additional key priority for the surgeon is to help the patients quickly recover their vision.

NTC has developed an innovative drug to appropriately manage the prevention of infection and to treat inflammation in patients after cataract surgery. In addition, NTC offers new products aimed at quickly restoring patients’ visual acuity after surgery (see section “Corneal edema”).